Louse metalloproteinases

Louse metalloproteinases are a group of enzymes essential for the physiological development and survival of human lice, including Pediculus humanus capitis (head louse) and Pediculus humanus humanus (body louse) [7, 9]. These enzymes are characterized by their requirement for divalent metal cofactors, such as iron (Fe), copper (Cu), and zinc (Zn), which are necessary for their catalytic function [2, 4]. They play a pivotal role in the life cycle of the parasite, particularly during the process of egg hatching (ovocidal activity) and the transition through various nymphal stages [1, 5]. By inhibiting these metalloproteinases, therapeutic agents can effectively kill both adult lice and their eggs, providing a comprehensive treatment for infestations [3, 6]. Abametapir is the primary therapeutic agent that targets these enzymes, acting as a metal chelator that sequesters the essential Fe, Cu, and Zn ions [8, 11]. This inhibition disrupts the enzymatic activity required for the louse to hatch from its egg and survive, offering a novel mechanism of action compared to traditional neurotoxic pediculicides [10, 12]. Because it targets a fundamental biological process rather than the nervous system, it is effective against louse populations that have developed resistance to other treatments [6, 7]. Clinical application involves a single topical treatment, which is generally well-tolerated, though it may cause local skin irritation and has the potential for systemic drug interactions through the inhibition of human cytochrome P450 enzymes [1, 8].

Other names

Metalloproteinases of Pediculus humanusLouse metalloproteasesMMPs

Inhibition of metalloproteinases through chelation of metal cofactors (Fe, Cu, Zn) essential for enzyme activity [2, 4].